|
42293738 |
0 |
Martens ESL, Mai V, Bates V, et al.
The diagnostic performance of the YEARS and Pulmonary Embolism Graduated D-dimer algorithms in patients with prior venous thrombosis suspected of pulmonary embolism.
Res Pract Thromb Haemost. 2026 Apr 30;10(4):106617. doi: 10.1016/j.rpth.2026.106617. eCollection 2026 May.
|
|
42058833 |
0 |
Mai V, Martens ESL, Righini M, et al.
Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism.
Res Pract Thromb Haemost. 2026 Mar 25;10(3):103442. doi: 10.1016/j.rpth.2026.103442. eCollection 2026 Mar.
|
|
41874920 |
0 |
Zhang Y, Yang W, Zhang J, et al.
The Gut Metabolite Phenylacetylglutamine Inhibits the Angiogenic Potential of Human Umbilical Vein Endothelial Cells Via the beta-Adrenergic Receptor-LDHA Axis.
J Cardiovasc Transl Res. 2026 Mar 24;19(1):43. doi: 10.1007/s12265-026-10764-w.
|
|
40578691 |
0 |
Mai V, Martens ESL, Righini M, et al.
Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study.
J Thromb Haemost. 2025 Jun 25:S1538-7836(25)00408-8. doi: 10.1016/j.jtha.2025.06.019.
|
|
40327961 |
0 |
Brown C, Mallick R, Pecarskie A, et al.
Letter-To-The-Editor: Long-term outcomes of patients with isolated subsegmental pulmonary embolism managed without anticoagulant therapy.
Thromb Res. 2025 Apr 30;250:109335. doi: 10.1016/j.thromres.2025.109335.
|
|
40315573 |
0 |
Du F, Wang Y, A W, et al.
Precision surface-immobilized peptide on graphene/chitosan composite sponge for rapid hemostasis of uncontrolled bleeding.
Colloids Surf B Biointerfaces. 2025 Sep;253:114757. doi: 10.1016/j.colsurfb.2025.114757. Epub 2025 Apr 30.
|
|
39445237 |
0 |
Narne KG, K I S N V, Kakumani J, et al.
Revealing an Exceptional Case of Budd-Chiari Syndrome.
Cureus. 2024 Sep 22;16(9):e69949. doi: 10.7759/cureus.69949. eCollection 2024 Sep.
|
|
39197347 |
0 |
Wang TF, Mallick R, Noureldin A, et al.
Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.
Thromb Res. 2024 Oct;242:109123. doi: 10.1016/j.thromres.2024.109123. Epub 2024 Aug 20.
|
|
36342561 |
0 |
Liu W, Li Z, Yang T, et al.
Association Between Platelet Glycoprotein IIb/IIIa Inhibition and In-Hospital Outcomes in ST-Elevation Myocardial Infarction Patients Treated with Coronary Thrombus Aspiration: Findings from the CCC-ACS Project.
Cardiovasc Drugs Ther. 2024 Apr;38(2):315-325. doi: 10.1007/s10557-022-07398-w. Epub 2022 Nov 7.
|
|
36100263 |
0 |
Auer RC, Ott M, Karanicolas P, et al.
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial.
BMJ. 2022 Sep 13;378:e071375. doi: 10.1136/bmj-2022-071375.
|
|
35664398 |
0 |
Kinikar AA, Vartak S, Dawre R, et al.
Clinical Profile and Outcome of Hospitalized Confirmed Cases of Omicron Variant of SARS-CoV-2 Among Children in Pune, India.
Cureus. 2022 Apr 30;14(4):e24629. doi: 10.7759/cureus.24629. eCollection 2022 Apr.
|
|
34807722 |
0 |
Le Gal G, Kovacs MJ, Bertoletti L, et al.
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.
Ann Intern Med. 2022 Jan;175(1):29-35. doi: 10.7326/M21-2981. Epub 2021 Nov 23.
|
, McMaster University